Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
buy in red market sell in green
:) should I hope for a red/bloody market?!!!!!!!! :0)
ATS is red @1.79 which is -5%, so when it turns green I am up +5% then there is the climb-do the math, uunderstand what a value red can be.
ied- nice and steady riser,, may not momo may just climb up every day.. I post 2.05,, and the spec shake in the 1.9's,, now I dont mind a slow and steady rise,, after all I am on my way to 4 and dont see much reason to keep reminding you that 2 was a good price
'Reggie_Hammonds' -it is called solid picking per charts or sector,,, either way they arent front run pump and dumps,, and now I can sit back and let others post all kinds of dd and reasons to buy,, today ANCC,, nobody wanted it last week at 1.10+/-
I try to give a flat or red entry,, it increases profit % when the run begins,, buying green 1)cuts your profit % 2)if you time it wrong you doubt the trade because it stalls for aminute or a day etc.
Ats-buy it red now or chase it later- there are no real sellers, so you can look forward to buyers
guess 1.10-1.11+/- wasnt interesting,, but 1.23+ is,,,hhhhhhmmm
vnwi-yawn
.01 cent pumpers in cln wont matter
thats the kaboom stock :)
stockpup-smart rat in a yacht!
stkr-looks like rats tumbling out of a sinking boat.
magic-do you see a kaboom in the works? :) shhhhhhhh
hygs fundies started in @$6.0
spec getting funny.,, Hhhhhhmm, still low vol
:)
sounds like stkr was trying to catch attention on old news with yesterdays pr,, hhhhhhhhmmmmmm, funny.
enjoy the ride,, got plenty of freebie posters lol
stockpup--sent out alert on that other one
ancc-and the nice part is,, we dont have to post about it, just enjoy the ride.
ied
cry later-PHYX,
Physiometrix Rated Speculative Buy in Initiating Coverage by Dutton & Associates
Tuesday March 9, 12:00 pm ET
EL DORADO HILLS, CA--(MARKET WIRE)--Mar 9, 2004 -- JM Dutton & Associates initiated coverage of Physiometrix (NasdaqSC:PHYX - News) with a Speculative Buy rating with a $4.50 price target. The 10-page report by JM Dutton senior analyst William Prather, R.Ph, M.D. is available at www.jmdutton.com as well as from Bloomberg, First Call, Zacks, Multex, and other leading financial portals.
ADVERTISEMENT
We consider Physiometrix to be a turnaround situation that, if successful, could provide significant upside to the value of the common stock. Physiometrix's Patient State Analyzer is a product with state-of-the-art technology in aiding the clinician obtain a real-time picture of the anesthetized or sedated patient's level of consciousness. We believe Physiometrix's technology is superior to the Bispectral Index (BIS) technology of their major competitor, Aspect Medical. However, we believe the strength of Physiometrix's revenues (and market value) are dependent upon the success of their marketing and distribution partner, Baxter Healthcare Corporation. We view the Baxter relationship as a significant risk to Physiometrix's valuation, and currently believe an investment should be considered only by risk-tolerant, speculative investors. However, if this relationship is successful, Physiometrix's market value could easily double over the next 12 months.
About Dutton & Associates
Dutton & Associates is one of the largest independent investment research firms in the U.S. Its 24 senior analysts are primarily CFAs, have expertise in many industries. Dutton & Associates provides continuing analyst coverage of over 65 enrolled companies, and its research, estimates, and ratings are carried in all the major databases serving institutions and online investors.
The cost of enrolment in our one-year continuing research program is US $28,000 prepaid before commencement of our research activities. We received $28,000 from the Company for coverage for the year, and do not accept payment of our fees in company stock. Our principals and analysts are prohibited from owning or trading in securities of covered companies. The views expressed in this research report accurately reflect the analyst's personal views about the subject securities or issuer. Neither the analyst's compensation nor the compensation received by us is in any way related to the specific ratings or views contained in this research report or note. Please read full disclosures and analyst background at www.jmdutton.com before investing.
Contact:
Contacts:
J.M. Dutton & Associates
John M. Dutton
916/941-4985
Physiometrix
John Williams
978/670-2422
yip-- it doesnt have any real sellers left,, easy money
nope--imax will higher soon-very soon
IMAX-theres your dip,, hhhhhhmmm, summer coming,, kids+movies=$
hygs gains momo after 6.50
vnwi-yawn per newsletter last night,,$2+ target per views and target set
phyx-new hod 1.70 t=4.50+/-
maybe I should just stick posting as they start running- be back later
well there goes HYGS-yawn
ats-a steal while red
ied
grow-nice tail play
ATS-way oversold
I have been pounding the table on that issue in newsletter,, and just sent this out instead of for each and every running stock:
you know when your stock is running,, I am trying to get you a good entry for that day,, ie: ancc etc,, I cant keep up with every runner in a timely fashion to remind you to take SOME profits- use good judgement,, let some free share ride for you.-this applies to all runners.
I figure the street will find ATS and PHYX soon
a bit early,, keeps testing that $4
grow,,holding-no worries,, trader stops getting hit
there are few 'alter-ego's at the pit,, notice the newcomers who are 'chatty'
hey the pit discovers CRAY